Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 May;33(5):781–784. doi: 10.1128/aac.33.5.781

Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.

R Shawar 1, M LaRocco 1, T G Cleary 1
PMCID: PMC172535  PMID: 2751289

Abstract

Ceftibuten is a new orally active cephalosporin with significant bioavailability. Its in vitro activity was compared with those of other agents against 383 strains of enteric pathogens derived from clinical specimens. Ceftibuten was very active against the strains of the family Enterobacteriaceae tested (overall MIC for 90% of strains tested, 0.25 microgram/ml) but was less active against Campylobacter jejuni (MIC for 90% of strains, 16 micrograms/ml). The MBC was one to two dilutions higher than the corresponding MICs for most pathogens tested.

Full text

PDF
781

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreasen J. J. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Denmark to fourteen antimicrobial agents. Acta Pathol Microbiol Immunol Scand B. 1987 Jun;95(3):189–192. doi: 10.1111/j.1699-0463.1987.tb03110.x. [DOI] [PubMed] [Google Scholar]
  2. Arisawa M., Ohshima J., Ohsawa E., Maruyama H. B., Sekine Y., Mitsuhashi S. Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins. Chem Pharm Bull (Tokyo) 1982 Jul;30(7):2544–2554. doi: 10.1248/cpb.30.2544. [DOI] [PubMed] [Google Scholar]
  3. Barada F. A., Jr, Guerrant R. L. Sulfamethoxazole- trimethoprim versus ampicillin in treatment of acute invasive diarrhea in adults. Antimicrob Agents Chemother. 1980 Jun;17(6):961–964. doi: 10.1128/aac.17.6.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carlson J. R., Thornton S. A., DuPont H. L., West A. H., Mathewson J. J. Comparative in vitro activities of ten antimicrobial agents against bacterial enteropathogens. Antimicrob Agents Chemother. 1983 Oct;24(4):509–513. doi: 10.1128/aac.24.4.509. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cherubin C. E. Antibiotic resistance of Salmonella in Europe and the United States. Rev Infect Dis. 1981 Nov-Dec;3(6):1105–1126. doi: 10.1093/clinids/3.6.1105. [DOI] [PubMed] [Google Scholar]
  6. DuPont H. L., Galindo E., Evans D. G., Cabada F. J., Sullivan P., Evans D. J., Jr Prevention of travelers' diarrhea with trimethoprim-sulfamethoxazole and trimethoprim alone. Gastroenterology. 1983 Jan;84(1):75–80. [PubMed] [Google Scholar]
  7. Gaudreau C. L., Lariviere L. A., Lauzer J. C., Turgeon F. F. Effect of clavulanic acid on susceptibility of Campylobacter jejuni and Campylobacter coli to eight beta-lactam antibiotics. Antimicrob Agents Chemother. 1987 Jun;31(6):940–942. doi: 10.1128/aac.31.6.940. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Goodman L. J., Fliegelman R. M., Trenholme G. M., Kaplan R. L. Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogens. Antimicrob Agents Chemother. 1984 Apr;25(4):504–506. doi: 10.1128/aac.25.4.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goossens H., Vanhoof R., De Mol P., Grados O., Ghysels G., Butzler J. P. In-vitro susceptibility of salmonellae to antimicrobial agents. J Antimicrob Chemother. 1984 Jun;13(6):559–565. doi: 10.1093/jac/13.6.559. [DOI] [PubMed] [Google Scholar]
  10. Gross R. J., Threlfall E. J., Ward L. R., Rowe B. Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim. Br Med J (Clin Res Ed) 1984 Mar 10;288(6419):784–786. doi: 10.1136/bmj.288.6419.784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hamashima Y., Kubota T., Minami K., Ishikura K., Konoike T., Yoshioka M., Yoshida T., Nakashimizu H., Motokawa K. Synthesis and biological properties of 7 beta-[(Z)-2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino]-3-cephem- 4-carboxylic acid (7432-S), a new oral cephem antibiotic. J Antibiot (Tokyo) 1987 Oct;40(10):1468–1470. doi: 10.7164/antibiotics.40.1468. [DOI] [PubMed] [Google Scholar]
  12. Handwerger S., Tomasz A. Antibiotic tolerance among clinical isolates of bacteria. Rev Infect Dis. 1985 May-Jun;7(3):368–386. doi: 10.1093/clinids/7.3.368. [DOI] [PubMed] [Google Scholar]
  13. Jones R. N., Barry A. L. Antimicrobial activity, spectrum, and recommendations for disk diffusion susceptibility testing of ceftibuten (7432-S; SCH 39720), a new orally administered cephalosporin. Antimicrob Agents Chemother. 1988 Oct;32(10):1576–1582. doi: 10.1128/aac.32.10.1576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kronborg I. J., Howard A. Diarrhoea: causes and specific treatment. Drugs. 1981 Jan;21(1):62–68. doi: 10.2165/00003495-198121010-00004. [DOI] [PubMed] [Google Scholar]
  15. Levine M. M. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis. 1987 Mar;155(3):377–389. doi: 10.1093/infdis/155.3.377. [DOI] [PubMed] [Google Scholar]
  16. Nakashima M., Uematsu T., Takiguchi Y., Mizuno A., Iida M., Yoshida T., Yamamoto S., Kitagawa K., Oguma T., Ishii H. Phase I clinical studies of 7432-S, a new oral cephalosporin: safety and pharmacokinetics. J Clin Pharmacol. 1988 Mar;28(3):246–252. doi: 10.1002/j.1552-4604.1988.tb03140.x. [DOI] [PubMed] [Google Scholar]
  17. Neu H. C., Meropol N. J., Fu K. P. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother. 1981 Mar;19(3):414–423. doi: 10.1128/aac.19.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pearson R. D., Steigbigel R. T., Davis H. T., Chapman S. W. Method of reliable determination of minimal lethal antibiotic concentrations. Antimicrob Agents Chemother. 1980 Nov;18(5):699–708. doi: 10.1128/aac.18.5.699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor P. C., Schoenknecht F. D., Sherris J. C., Linner E. C. Determination of minimum bactericidal concentrations of oxacillin for Staphylococcus aureus: influence and significance of technical factors. Antimicrob Agents Chemother. 1983 Jan;23(1):142–150. doi: 10.1128/aac.23.1.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Van der Auwera P., Scorneaux B. In vitro susceptibility of Campylobacter jejuni to 27 antimicrobial agents and various combinations of beta-lactams with clavulanic acid or sulbactam. Antimicrob Agents Chemother. 1985 Jul;28(1):37–40. doi: 10.1128/aac.28.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vanhoof R., Gordts B., Dierickx R., Coignau H., Butzler J. P. Bacteriostatic and bactericidal activities of 24 antimicrobial agents against Campylobacter fetus subsp. jejuni. Antimicrob Agents Chemother. 1980 Jul;18(1):118–121. doi: 10.1128/aac.18.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Vanhoof R., Hubrechts J. M., Roebben E., Nyssen H. J., Nulens E., Leger J., De Schepper N. The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms. Infection. 1986 Nov-Dec;14(6):294–298. doi: 10.1007/BF01643966. [DOI] [PubMed] [Google Scholar]
  23. von Graevenitz A., Bucher C. The effect of N-formimidoyl thienamycin, ceftazidime, cefotiam, ceftriaxone and cefotaxime on non-fermentative Gram-negative rods, Aeromonas, Plesiomonas and Enterobacter agglomerans. Infection. 1982 Sep-Oct;10(5):293–298. doi: 10.1007/BF01640878. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES